Pasithea Therapeutics KTTAW
NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT

Pasithea Therapeutics Corp. (KTTAW) Times Interest Earned (2023)

Pasithea Therapeutics' (KTTAW) quarterly Times Interest Earned came in at 32.67 in Q2 2023, up 106.5% quarter-over-quarter from 502.9 in Q1 2023.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Pasithea Therapeutics Corp. (KTTAW) Times Interest Earned (2023) Analysis & Trends

Pasithea Therapeutics has disclosed Times Interest Earned across 1 years of filings, most recently posting 32.67 for Q2 2023.

Peer Set

Peer Comparison

All peers
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 32.67
Mar 31, 2023 -502.90